Defined Sleep’s research team will also present evidence-based sleep hygiene strategies to improve mental well-being at the APA 2024 conference.


Summary: Defined Sleep, a developer of CBD sleep supplements, will showcase its latest research at the American Psychiatric Association (APA) 2024 Annual Meeting in New York City. Led by Paul Muchowski, PhD, the team will highlight evidence-based strategies to enhance sleep hygiene and improve mental health. Key features include discussions on integrating sleep management into clinical practice and showcasing Defined Sleep’s supplement, which uses a rational drug design with eight terpenes amplifying CBD. The supplement is backed by a clinical trial.

Key Takeaways:

  • The Defined Sleep team will showcase research on its CBD sleep supplement, which uses a rational drug design with eight terpenes to amplify CBD’s effects, supported by a clinical trial.
  • Defined Sleep will present evidence-based sleep hygiene strategies at the APA 2024 Annual Meeting to help mental health professionals integrate better sleep management into clinical practice.
  • Defined Sleep aims to bridge the gap between sleep science and mental health care, providing actionable solutions that enhance overall well-being through improved sleep hygiene.

Defined Sleep, a developer of CBD sleep supplements, will showcase its latest research findings at the American Psychiatric Association (APA) 2024 Annual Meeting in New York City. 

The Defined Sleep research team, led by Paul Muchowski, PhD, will highlight evidence-based strategies for enhancing sleep hygiene to improve overall mental well-being.

Key Features of Defined Sleep’s participation in this meeting:

  • Evidence-based research: Latest studies demonstrating the impact of sleep management on mental health.
  • Expertise in science: The founder of Defined Sleep will share information about practical sleep hygiene techniques for mental health professionals.
  • Networking opportunities: Discussions on how mental health practitioners can integrate these insights into their clinical practice.

“We are excited to bring our cutting-edge research to the forefront at the APA 2024 conference,” says Muchowski, founder and lead researcher at Defined Sleep, in a release. “Our commitment is to bridge the gap between sleep science and mental health care, providing actionable solutions that practitioners can apply in their work.”

Defined Sleep’s involvement in the APA conference “underscores its dedication to fostering deeper understanding and innovation in mental health care through improved sleep science,” according to a release from the company. 

The Defined Sleep CBD sleep supplement uses a rational drug design that includes eight terpenes, which act as amplifiers for CBD. The supplement is backed by a clinical trial.